We Think Guanze Medical Information Industry (Holding) (HKG:2427) Can Stay On Top Of Its Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when you assess how risky a company is. Importantly, Guanze Medical Information Industry (Holding) Co., Ltd. (HKG:2427) does carry debt. But the more important question is: how much risk is that debt creating?

Advertisement

Why Does Debt Bring Risk?

Debt is a tool to help businesses grow, but if a business is incapable of paying off its lenders, then it exists at their mercy. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. However, a more common (but still painful) scenario is that it has to raise new equity capital at a low price, thus permanently diluting shareholders. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. The first step when considering a company's debt levels is to consider its cash and debt together.

Check out our latest analysis for Guanze Medical Information Industry (Holding)

What Is Guanze Medical Information Industry (Holding)'s Debt?

The image below, which you can click on for greater detail, shows that Guanze Medical Information Industry (Holding) had debt of CN¥18.5m at the end of June 2024, a reduction from CN¥30.8m over a year. However, it does have CN¥49.6m in cash offsetting this, leading to net cash of CN¥31.1m.

debt-equity-history-analysis
SEHK:2427 Debt to Equity History November 4th 2024

A Look At Guanze Medical Information Industry (Holding)'s Liabilities

The latest balance sheet data shows that Guanze Medical Information Industry (Holding) had liabilities of CN¥34.3m due within a year, and liabilities of CN¥278.0k falling due after that. On the other hand, it had cash of CN¥49.6m and CN¥99.0m worth of receivables due within a year. So it can boast CN¥114.0m more liquid assets than total liabilities.

This surplus suggests that Guanze Medical Information Industry (Holding) is using debt in a way that is appears to be both safe and conservative. Given it has easily adequate short term liquidity, we don't think it will have any issues with its lenders. Simply put, the fact that Guanze Medical Information Industry (Holding) has more cash than debt is arguably a good indication that it can manage its debt safely.

The modesty of its debt load may become crucial for Guanze Medical Information Industry (Holding) if management cannot prevent a repeat of the 57% cut to EBIT over the last year. Falling earnings (if the trend continues) could eventually make even modest debt quite risky. When analysing debt levels, the balance sheet is the obvious place to start. But it is Guanze Medical Information Industry (Holding)'s earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

Finally, a business needs free cash flow to pay off debt; accounting profits just don't cut it. Guanze Medical Information Industry (Holding) may have net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Over the last three years, Guanze Medical Information Industry (Holding) recorded negative free cash flow, in total. Debt is far more risky for companies with unreliable free cash flow, so shareholders should be hoping that the past expenditure will produce free cash flow in the future.

Summing Up

While it is always sensible to investigate a company's debt, in this case Guanze Medical Information Industry (Holding) has CN¥31.1m in net cash and a decent-looking balance sheet. So we are not troubled with Guanze Medical Information Industry (Holding)'s debt use. The balance sheet is clearly the area to focus on when you are analysing debt. However, not all investment risk resides within the balance sheet - far from it. Case in point: We've spotted 5 warning signs for Guanze Medical Information Industry (Holding) you should be aware of, and 2 of them can't be ignored.

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About SEHK:2427

Guanze Medical Information Industry (Holding)

An investment holding company, provides medical imaging solutions in the People’s Republic of China.

Flawless balance sheet with proven track record.

Advertisement

Weekly Picks

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8229.7% undervalued
71 users have followed this narrative
5 users have commented on this narrative
34 users have liked this narrative
WO
BMBL logo
woodworthfund on Bumble ·

Swiped Left by Wall Street: The BMBL Rebound Trade

Fair Value:US$960.1% undervalued
22 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
WE
WealthAP
DUOL logo
WealthAP on Duolingo ·

Duolingo (DUOL): Why A 20% Drop Might Be The Entry Point We've Been Waiting For

Fair Value:US$268.6441.8% undervalued
43 users have followed this narrative
5 users have commented on this narrative
9 users have liked this narrative
AN
andre_santos
RACE logo
andre_santos on Ferrari ·

Ferrari's Intrinsic and Historical Valuation

Fair Value:€243.5626.4% overvalued
8 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative

Updated Narratives

LE
NOVO B logo
LeStockPicker on Novo Nordisk ·

Probably the best stock I've seen all year.

Fair Value:DKK 90058.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DE
HIMS logo
Deep_Insights on Hims & Hers Health ·

Hims & Hers Health aims for three dimensional revenue expansion

Fair Value:US$173.0281.9% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
RO
RockeTeller
THX logo
RockeTeller on Thor Explorations ·

West Africa's 20 Baggers Gold Play (Nigeria/Senegal)

Fair Value:CA$3295.6% undervalued
3 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

WE
WealthAP
PYPL logo
WealthAP on PayPal Holdings ·

The "Sleeping Giant" Stumbles, Then Wakes Up

Fair Value:US$8229.7% undervalued
71 users have followed this narrative
5 users have commented on this narrative
34 users have liked this narrative
AL
RKLB logo
AlexLovell on Rocket Lab ·

Early mover in a fast growing industry. Likely to experience share price volatility as they scale

Fair Value:US$16.25464.9% overvalued
75 users have followed this narrative
1 users have commented on this narrative
18 users have liked this narrative
AG
Agricola
EXN logo
Agricola on Excellon Resources ·

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Fair Value:CA$31.898.3% undervalued
72 users have followed this narrative
15 users have commented on this narrative
23 users have liked this narrative

Trending Discussion

WA
Wane_Investment_House
AIRTELAFRI logo
Wane_Investment_House on Airtel Africa ·

Airtel Africa Plc – Recalibrated Valuation Highlights Compelling Relative Value Equity analysts highlight that Airtel’s stock remains undervalued relative to regional peers, presenting an attractive entry point for investors seeking exposure to a resilient, data-driven telecom business. Strategic Insights • Revenue Mix Transformation: The transition from voice to data highlights Airtel’s alignment with global telecom trends and positions the company to capture higher-margin opportunities in mobile data and digital services. • Operational Levers: Subscriber growth, tariff adjustments, and disciplined cost management provide a solid foundation for near-term growth. • Valuation Drivers: Adjustments to the equity risk premium (13.8% vs. 14.3%) and lower yields on Nigeria’s 10-year Eurobond (7.7% vs. 10.4%) have slightly tempered valuation, but the fundamentals remain strong. Analyst Commentary • Near-term Upside: The revised target price suggests significant potential gains, particularly given Airtel’s operational resilience and structural growth in data usage. • Investment Considerations: Investors seeking exposure to defensive growth in telecom should view Airtel as a long-term opportunity, with upside supported by undervaluation relative to regional peers. • Risk Factors: Currency appreciation (Naira strength), potential regulatory changes, and macroeconomic volatility remain key considerations for risk-adjusted returns. Conclusion Airtel Africa Plc combines robust operational performance, a favorable shift to data revenue, and strategic macro positioning with an undervalued stock price relative to peers. Despite muted market response in 2025, the recalibrated target price and potential upside of 72% underscore Airtel’s attractiveness for long-term investors seeking resilient, growth-oriented exposure in the African telecom sector.

0
|
0
US
PLUG logo
User on Plug Power ·

Which is where?

0
|
0
Advertisement